Horton, C., Davies, T., Lahiri, P., Sachamitr, P., & Fairchild, P. (2019). iPS cells reprogrammed from primary dendritic cells provide an abundant source of immunostimulatory dendritic cells for use in immunotherapy. Wiley.

Horton, C., TJ Davies, P. Lahiri, P. Sachamitr, and PJ Fairchild. IPS Cells Reprogrammed from Primary Dendritic Cells Provide an Abundant Source of Immunostimulatory Dendritic Cells for Use in Immunotherapy. Wiley, 2019.

Horton, C., et al. IPS Cells Reprogrammed from Primary Dendritic Cells Provide an Abundant Source of Immunostimulatory Dendritic Cells for Use in Immunotherapy. Wiley, 2019.